Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $3.87B | $3.79B | +2.22% |
Gross Profit | $2.33B | $2.24B | +3.76% |
Net Income | $863.14M | $788.78M | +9.43% |
EPS (Basic) | $40.67 | $36.10 | +12.66% |
EPS (Diluted) | $40.48 | $35.90 | +12.76% |
R&D Expense | $189.36M | $185.28M | +2.20% |
SG&A Expense | $936.3M | $904.11M | +3.56% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.24B | $3.36B | -3.44% |
Current Assets | $1.19B | $1.23B | -2.95% |
Total Liabilities | $3.37B | $3.51B | -3.95% |
Current Liabilities | $1.17B | $1.18B | -1.09% |
Stockholders' Equity | $-126.89M | $-149.94M | +15.37% |
Long-Term Debt | $1.83B | $1.89B | -3.04% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $968.35M | $965.87M | +0.26% |
Investing Cash Flow | $-119.46M | $-131.69M | +9.29% |
Financing Cash Flow | $-855.98M | $-859.59M | +0.42% |
Share Buybacks | $850M | $900M | -5.56% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 60.1% | 59.2% | +0.89% |
Net Margin | 22.3% | — | — |
ROE | -680.2% | — | — |
ROA | 26.6% | — | — |
Current Ratio | $1.022 | — | — |
Debt to Equity | $-26.534 | — | — |
Other companies in Life Sciences Tools & Services